Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 30.40
-0.25 (-0.82%)
At close: Mar 3, 2026
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 5.78 billion as of March 3, 2026. Its market cap has increased by 1.49% in one year.
Market Cap
5.78B
Enterprise Value
6.72B
Revenue
3.35B
Ranking
n/a
PE Ratio
16.80
Stock Price
30.40
Market Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 5.78B, an increase of 413.77%. That is a compound annual growth rate of 7.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.78B | -0.33% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 6.84B |
| Savior Lifetec | 5.88B |
| Steminent Biotherapeutics | 5.85B |
| AnnJi Pharmaceutical | 5.61B |
| OBI Pharma | 5.50B |
| CHO Pharma | 5.49B |
| Locus Cell | 5.42B |
| Panion & Bf Biotech | 5.36B |